Artemisinins are very poweful tools in the treatment of malaria, and the emerging loss of their activity has the potential to create a major public health problem. MALARIA TREATMENT
Dr Charlie Woodrow is based at MORU in Bangkok, Thailand, where he coordinates clinical and laboratory studies on resistance to artemisinins. Bringing together diverse datasets ... Show More
Dec 2023
What kind of a problem is loneliness? Studying technology to understand policy concerns
This talk by Dr Gemma Hughes is intended to show how problems, such as loneliness, can be understood and researched in multiple ways. By outlining the methodology of the research programme Virtual Presence, and explaining the qualitative methods used to study the adoption of tele ... Show More
43m 59s
Mar 2015
Emerging Infectious Diseases
Professor Peter Horby is Senior Clinical Research Fellow. His research focusses on epidemic diseases such as Ebola and bird flu, and crosses the disciplines of basic science, medical science and public health. Influenza, SARS & Ebola
Research on emerging infectious diseases can o ... Show More
6m 12s
Oct 2021
Drug resistant malaria found in East Africa
Since their discovery in the 1970s, artemisinin-based drugs have become the mainstay of treatment for malaria caused by the Plasmodium falciparum parasite. Researchers have identified artemisinin-resistant malaria parasites in Southeast Asia since the early 2000s, but now, there ... Show More
1h 1m
Dec 2022
Minocycline Pharmacology Podcast
Minocycline is a tetracycline antibiotic. I discuss pharmacology, adverse effects, and drug interactions.
Minocycline can cause sun sensitivity. Be sure to educate patients about this risk.
Metal cations like iron, zinc, calcium, and magnesium can bind minocycline and red ... Show More
14m 6s